EXL announces speakers for AI in Action event
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading data analytics, digital operations and solutions company, […]
Lottery.com Regains Full Nasdaq Compliance
AUSTIN, Texas, April 11, 2024 (GLOBE NEWSWIRE) — Lottery.com, Inc. (the “Company”) has received written notice from the Listing Qualifications […]
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery
LYNX-2 Follows SPA Agreement with FDA Development of PS is Funded by Ocuphire’s Partner Viatris FARMINGTON HILLS, Mich., April 11, […]
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
HOUSTON, April 11, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued […]
OceanPal Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2023
ATHENS, Greece, April 11, 2024 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in […]
ContextLogic Urges Stockholders to Vote FOR the Value Maximizing Transaction with Qoo10 TODAY
Today is Last Day for ContextLogic Stockholders to Vote at Upcoming Special Meeting Critical that Stockholders Approve Transaction to Protect […]
Palisade Bio to Participate in the Virtual Investor Lunch Break Event
– Live webcast with members of Palisade Bio management on Tuesday, April 16that 12:00 PM ET Carlsbad, CA, April 11, 2024 […]
WeightWatchers Appoints New Executive Leaders
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment […]
Backblaze Completes Trusted Partner Network Assessment, Receiving Blue Shield Status
SAN MATEO, Calif., April 11, 2024 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the leading specialized storage cloud, today announced […]
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
NEEDHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage […]
